wegovy weight loss drug - Search News

FDA, Weight loss and diabetes drugs

Hosted on MSN · 16h

Novo’s Weight Loss Drugs Removed from FDA Shortage List

The FDA said weight-loss and diabetes drugs Wegovy and Ozempic are no longer on shortage list. The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and diabetes drugs,

The Washington Post · 1d

Weight-loss drugs aren’t just slimming waists. They’re shifting the economy.

Ozempic, Mounjaro and Wegovy may not be the lightbulb, jet airplane or internet, but their impact is expected to be so significant it could shift GDP.

The Associated Press on MSN · 2d

Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says

In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., also had been resolved. Zepbound is approved to treat obesity and Mounjaro is approved for diabetes. They use the same active ingredient, tirzepatide.

2don MSN

New weight-loss drugs like Mounjaro are hot right now. Eli Lilly's CEO explains why they're so expensive.

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous value they offer.

3d

The next phase of the weight-loss revolution holds promise — and peril

A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results